Neurotech International Ltd
NTI
Company Profile
Business description
Neurotech International Ltd is a medical device and solutions company conducting clinical studies to assess the neuroprotective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. Geographically, all the firm's business activities function through the region of Australia. It operates in one segment: Medical Device Development and Distribution.
Contact
145 Stirling Highway
Suite 5 CPC
NedlandsWA6009
AUST: +61 893893130
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
18
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,369.30 | 4.70 | -0.06% |
| CAC 40 | 7,690.26 | 37.67 | -0.49% |
| DAX 40 | 23,160.61 | 183.93 | -0.79% |
| Dow JONES (US) | 40,877.89 | 340.94 | -0.83% |
| FTSE 100 | 8,585.94 | 10.41 | -0.12% |
| HKSE | 22,662.71 | 158.03 | 0.70% |
| NASDAQ | 17,631.26 | 212.98 | -1.19% |
| Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
| NZX 50 Index | 12,421.09 | 0.16 | -0.00% |
| S&P 500 | 5,597.64 | 52.74 | -0.93% |
| S&P/ASX 200 | 8,151.40 | 6.40 | -0.08% |
| SSE Composite Index | 3,316.11 | 37.08 | 1.13% |